Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis (Q28067038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis (English)

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

3

Daniela Amicizia

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

5

Roberto Gasparini

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1

Alexander Domnich

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

6

Donatella Panatto

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Lucia Arata

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

1 reference

23 December 2016

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

513-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28024956%20AND%20SRC:MED&resulttype=core&format=json

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Evaluating the case for trivalent or quadrivalent influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

The rationale for quadrivalent influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

The Measurement of Observer Agreement for Categorical Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011

Effectiveness of influenza vaccination in institutionalized older adults: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.011